EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical SMN1 and SMN2 Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing

Cecelia R Miller, Jin Fang, Pamela Snyder, Susan E Long, Thomas W Prior, Dan Jones, Matthew R Avenarius iD

Human Mutation · 2023

DOI: 10.1155/2023/6436853 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2023. Verfasst von Cecelia R Miller und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Ohio State University Wexner Medical Center, Department of Pathology, 6100 Optometry Clinic & Health Science Faculty Office Building, 1664 Neil A…. Hauptthemen laut MEDLINE: Survival of Motor Neuron 1 Protein, Muscular Atrophy, Spinal, Survival of Motor Neuron 2 Protein. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Therapeutic advances in the treatment of spinal muscular atrophy (SMA) prompt the need for robust and efficient molecular diagnosis of this disease. Approximately five percent of SMA cases are attributable to one copy of SMN1 with a hypomorphic or inactivating variant in trans with a deleted or converted allele. These intragenic variants are challenging to definitively localize to SMN1 due to its sequence homology with the SMN2 gene. To enhance the clinical sensitivity of SMA diagnostic testing, we present an optimized gene-specific sequencing assay to localize variants to either SMN1 or SMN2.

Methods

SMN1 and SMN2 genes are independently amplified by long-range allele-specific PCR. Long-range products are used in subsequent nested PCR reactions to amplify the coding exons of SMN1 and SMN2. The resulting products are sequenced using standard Sanger-based methodologies and analyzed for disease-associated alterations.

Results

83 probands suspicious for a clinical diagnosis of SMA with a nondiagnostic SMN dosage result were sequenced for intragenic variants in the SMN1 gene. Gene-specific sequencing revealed likely disease-associated variants in SMN1 in 42 cases (50.6%). Of the 42 variants, 27 are unique including 16 loss-of-function variants, 9 missense variants, 1 in-frame deletion variant, and 1 splice site variant.

Conclusions

Herein, we describe an optimized assay for clinical sequencing of the full coding region of SMN1 and SMN2. This assay uses standard techniques and equipment readily available to most molecular diagnostic laboratories.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Survival of Motor Neuron 1 ProteinMuscular Atrophy, SpinalSurvival of Motor Neuron 2 ProteinHumansSequence Analysis, DNAMutationAllelesGenetic TestingExonsSensitivity and Specificity

Substanzen

Survival of Motor Neuron 1 ProteinSurvival of Motor Neuron 2 ProteinSMN2 protein, humanSMN1 protein, human

Autor:innen und Institutionen

  • The Ohio State University Wexner Medical Center, Department of Pathology, 6100 Optometry Clinic & Health Science Faculty Office Building, 1664 Neil Avenue, Columbus, OH 43210, USA.
  • The Ohio State University James Comprehensive Cancer Center Molecular Pathology Laboratory, 2001 Polaris Parkway, Columbus, OH 43240, USA.
  • Case Western Reserve, Department of Pathology, 10900 Euclid Avenue, Cleveland, OH 44106, USA.

ORCID-Profile: Matthew R Avenarius

Zitieren

APA

Miller, C. R., Fang, J., Snyder, P., Long, S. E., Prior, T. W., Jones, D., & Avenarius, M. R. (2023). Clinical SMN1 and SMN2 Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing. Human Mutation. https://doi.org/10.1155/2023/6436853

Vancouver

Miller CR, Fang J, Snyder P, Long SE, Prior TW, Jones D, et al. Clinical SMN1 and SMN2 Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing. Human Mutation. 2023. doi:10.1155/2023/6436853

BibTeX
@article{Miller2023,
  author = {Miller, Cecelia R and Fang, Jin and Snyder, Pamela and Long, Susan E and Prior, Thomas W and Jones, Dan and Avenarius, Matthew R},
  title = {Clinical SMN1 and SMN2 Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing},
  journal = {Human Mutation},
  year = {2023},
  doi = {10.1155/2023/6436853}
}
Kostenlos starten →